TAKTakeda Pharmaceutical Company Limited

$18.25

$13.2352 weeks$18.80

Price

$18.25+27%1Y

1M+8.4%1Y+27%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average

8/10

Value66

Quality77

Momentum46

Growth43

Strongest Quality, weakest Growth · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

We are a global R&D-driven biopharmaceutical company focused on discovering and delivering life-transforming treatments in our core therapeutic areas of gastrointestinal and inflammation, neuroscience and oncology, as well as through our plasma-derived therapies and vaccines business. Our intent is to translate science into highly innovative life-transforming medicines. We have built an R&D engine focused on three core therapeutic areas, leveraging internal research and external partners in order to have access to different modalities like biologics or small molecules.

In the company’s own words · 20-F filed Jun 17, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$49.39B

1Y Return+27%

5Y Return+16%

For the full year FY2025, revenue was JPY 4.58T (+7.5% year on year) and net income JPY 107.9B.